1. Homologous Recombination Deficiency and Tumor Mutational Burden as Clinical Biomarkers for Melanoma. (9th November 2022) Authors: Yip, J; Lum, C; Halford, Z; Pon, J; Woron, A Journal: American journal of clinical pathology Issue: Volume 158(2022)Supplement 1 Page Start: S144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗